Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds
Abstract Background It is largely unknown how alcohol use affects the risk of Alzheimer`s disease (AD). Therefore, studies on the influence of alcohol use on cerebrospinal fluid (CSF) biomarkers for the earliest preclinical phase of AD are needed. Methods This was a cross-sectional cohort study. The...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-025-01819-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849237650279497728 |
|---|---|
| author | Silke Kern Tobias Skillbäck Henrik Zetterberg Anna Dittrich Felicia Ahlner Anna Zettergren Margda Waern Nazib M Seidu Ulf Andreasson Kaj Blennow Ingmar Skoog |
| author_facet | Silke Kern Tobias Skillbäck Henrik Zetterberg Anna Dittrich Felicia Ahlner Anna Zettergren Margda Waern Nazib M Seidu Ulf Andreasson Kaj Blennow Ingmar Skoog |
| author_sort | Silke Kern |
| collection | DOAJ |
| description | Abstract Background It is largely unknown how alcohol use affects the risk of Alzheimer`s disease (AD). Therefore, studies on the influence of alcohol use on cerebrospinal fluid (CSF) biomarkers for the earliest preclinical phase of AD are needed. Methods This was a cross-sectional cohort study. The sample (n = 301) was derived from the 2014–2016 examinations of the Gothenburg H70 Birth Cohort Studies. The study cohort consisted of 301 70-year-old women and men, where of 246 cognitively unimpaired and 55 with mild cognitive deficits. Information on alcohol consumption (g/week and type of alcohol) was collected and CSF amyloid-β1−42 (Aβ42), total-tau (T-tau), tau phosphorylated at threonine 181 (P-tau181), neurofilament light protein (NfL) and neurogranin (Ng) were measured. We tested the association between the CSF biomarkers and alcohol consumption types using correlation and linear regression, adjusting for possible confounders when necessary according to the performed sensitivity analysis. Results There were no correlations between weekly alcohol consumption and any of the CSF markers studied in the total sample of cognitively unimpaired participants (n = 246). After adjustments for multiplicity with FDR, there was an association between white wine and Ng in women with CDR = 0 (β:0.254, CI: ( 0.069: 0.439), p = 0.0076, FDR = 0.0455). Interaction analysis between female sex and red wine intake was a significant predictor of high Ng levels (β:0.410, CI: ( 0.099: 0.721), p = 0.0100, FDR = 0.0500). There were no correlations between consumption of specific types of alcohol (spirits, white wine, red wine, fortified wine, and beer) and any of the biomarkers studied in the total sample of cognitively unimpaired participants. Conclusions Our findings indicate that higher alcohol use in older cognitively unimpaired women correlates with a biomarker of synaptic dysfunction in AD, which is an important observation in a time when alcohol use is increasing among women. |
| format | Article |
| id | doaj-art-e8f18c65bba844568bfc812ac60b2793 |
| institution | Kabale University |
| issn | 1758-9193 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Alzheimer’s Research & Therapy |
| spelling | doaj-art-e8f18c65bba844568bfc812ac60b27932025-08-20T04:01:53ZengBMCAlzheimer’s Research & Therapy1758-91932025-07-011711910.1186/s13195-025-01819-2Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-oldsSilke Kern0Tobias Skillbäck1Henrik Zetterberg2Anna Dittrich3Felicia Ahlner4Anna Zettergren5Margda Waern6Nazib M Seidu7Ulf Andreasson8Kaj Blennow9Ingmar Skoog10Department of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgClinical Neurochemistry Laboratory Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgClinical Neurochemistry Laboratory Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgClinical Neurochemistry Laboratory Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgDepartment of Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of GothenburgAbstract Background It is largely unknown how alcohol use affects the risk of Alzheimer`s disease (AD). Therefore, studies on the influence of alcohol use on cerebrospinal fluid (CSF) biomarkers for the earliest preclinical phase of AD are needed. Methods This was a cross-sectional cohort study. The sample (n = 301) was derived from the 2014–2016 examinations of the Gothenburg H70 Birth Cohort Studies. The study cohort consisted of 301 70-year-old women and men, where of 246 cognitively unimpaired and 55 with mild cognitive deficits. Information on alcohol consumption (g/week and type of alcohol) was collected and CSF amyloid-β1−42 (Aβ42), total-tau (T-tau), tau phosphorylated at threonine 181 (P-tau181), neurofilament light protein (NfL) and neurogranin (Ng) were measured. We tested the association between the CSF biomarkers and alcohol consumption types using correlation and linear regression, adjusting for possible confounders when necessary according to the performed sensitivity analysis. Results There were no correlations between weekly alcohol consumption and any of the CSF markers studied in the total sample of cognitively unimpaired participants (n = 246). After adjustments for multiplicity with FDR, there was an association between white wine and Ng in women with CDR = 0 (β:0.254, CI: ( 0.069: 0.439), p = 0.0076, FDR = 0.0455). Interaction analysis between female sex and red wine intake was a significant predictor of high Ng levels (β:0.410, CI: ( 0.099: 0.721), p = 0.0100, FDR = 0.0500). There were no correlations between consumption of specific types of alcohol (spirits, white wine, red wine, fortified wine, and beer) and any of the biomarkers studied in the total sample of cognitively unimpaired participants. Conclusions Our findings indicate that higher alcohol use in older cognitively unimpaired women correlates with a biomarker of synaptic dysfunction in AD, which is an important observation in a time when alcohol use is increasing among women.https://doi.org/10.1186/s13195-025-01819-2Alcohol consumptionBiomarkersCerebrospinal fluidAlzheimer’s diseaseAβ42P-tau |
| spellingShingle | Silke Kern Tobias Skillbäck Henrik Zetterberg Anna Dittrich Felicia Ahlner Anna Zettergren Margda Waern Nazib M Seidu Ulf Andreasson Kaj Blennow Ingmar Skoog Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds Alzheimer’s Research & Therapy Alcohol consumption Biomarkers Cerebrospinal fluid Alzheimer’s disease Aβ42 P-tau |
| title | Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds |
| title_full | Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds |
| title_fullStr | Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds |
| title_full_unstemmed | Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds |
| title_short | Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds |
| title_sort | alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer s disease in a population based sample of 70 year olds |
| topic | Alcohol consumption Biomarkers Cerebrospinal fluid Alzheimer’s disease Aβ42 P-tau |
| url | https://doi.org/10.1186/s13195-025-01819-2 |
| work_keys_str_mv | AT silkekern alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT tobiasskillback alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT henrikzetterberg alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT annadittrich alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT feliciaahlner alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT annazettergren alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT margdawaern alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT nazibmseidu alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT ulfandreasson alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT kajblennow alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds AT ingmarskoog alcoholconsumptionandcerebrospinalfluidbiomarkersforpreclinicalalzheimersdiseaseinapopulationbasedsampleof70yearolds |